No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹1,258Prev. Close
₹1,242.7Turnover(Lac.)
₹353.05Day's High
₹1,258Day's Low
₹1,20652 Week's High
₹1,74052 Week's Low
₹752Book Value
₹263.28Face Value
₹10Mkt Cap (₹ Cr.)
4,103.87P/E
171.88EPS
7.23Divi. Yield
0.08The company informed that its fund raising committee approved a floor price of ₹1,615.28 per equity share on December 15, 2025.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 28.64 | 25.85 | 25.16 | 25.16 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 288.73 | 95.93 | 69.3 | 66.21 |
Net Worth | 317.37 | 121.78 | 94.46 | 91.37 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 106.84 | 95.08 | 85.62 | 77.84 |
yoy growth (%) | 12.36 | 11.03 | 10 | 8.75 |
Raw materials | -73.34 | -66.3 | -57.01 | -51.03 |
As % of sales | 68.64 | 69.72 | 66.58 | 65.56 |
Employee costs | -9.3 | -10.34 | -8.89 | -6.63 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -1.34 | 3.88 | 7.85 | 11.36 |
Depreciation | -3.16 | -2.09 | -1.39 | -0.93 |
Tax paid | 0.15 | -1.12 | -2.3 | -4.07 |
Working capital | 2.77 | -2.38 | 8.18 | 12.04 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 12.36 | 11.03 | 10 | 8.75 |
Op profit growth | -85.09 | -41.46 | -28.94 | 8.56 |
EBIT growth | -131.25 | -49.98 | -31.23 | 26.97 |
Net profit growth | -105.88 | -50.28 | -23.6 | 31.15 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 292.97 | 180.49 | 139.96 | 131.19 | 106.79 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 292.97 | 180.49 | 139.96 | 131.19 | 106.79 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.07 | 1.16 | 2.49 | 1.63 | 2.29 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,737 | 98.11 | 4,28,185.32 | 705.44 | 0.9 | 5,651.21 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,408.5 | 66.77 | 1,71,766.14 | 598 | 0.46 | 2,578 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,333.3 | 66.68 | 1,48,922.76 | 577 | 0.14 | 2,547 | 249.82 |
Dr Reddys Laboratories Ltd DRREDDY | 1,286.3 | 23.73 | 1,10,081.07 | 90.6 | 0.61 | 4,266.4 | 377.55 |
Cipla Ltd CIPLA | 1,348.2 | 23.94 | 1,09,680.46 | 616.88 | 1.18 | 4,256.93 | 411.55 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Non Executive Dir.
Ketankumar Zota
Executive Director & MD
Moxesh Zota
WTD & Executive Director
Himanshu Zota
WTD & Executive Director
Kamlesh Zota
WTD & Executive Director
Viren Manukant Zota
Executive Director
Laxmi Kant Sharma
Independent Non Exe. Director
Varsaben Mehta
Independent Non Exe. Director
Bhumi Maulik Doshi
Independent Non Exe. Director
Vitrag Sureshkumar Modi
Independent Non Exe. Director
Dhiren Prafulbhai Shah
Independent Non Exe. Director
Jayshreeben Nileshkumar Mehta
Independent Non Exe. Director
Dhaval Chandubhai Patwa
Company Sec. & Compli. Officer
Ashvin Variya
Zota House 2/896 Hira Modi St,
Sagrampura,
Gujarat - 395002
Tel: 91-261-2331601
Website: http://www.zotahealthcare.com
Email: info@zotahealthcare.com
Unit-49 Bldg-13 AB,
Off Andheri Kurla Rd, MTNL Lane Sakinaka,
Mumbai-400072
Tel: 91-22-28520461
Website: www.satellitecorporate.com
Email: service@satellitecorporate.com
Summary
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products. The Company was inc...
Read More
Reports by Zota Health Care Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.